H. pylori - Ace Therapeutics
Basic and Supporting Research on H. pylori
Online Inquiry

Basic and Supporting Research on H. pylori

Improved understanding of disease microbes can help develop new treatment options. H. pylori are pathogenic bacteria that cause a variety of diseases. Ace Therapeutics provides basic and supporting research services for H. pylori to help study the relationship between H. pylori and its pathogenicity. These basic and supporting studies can help to find solutions for the realization of vaccines and therapeutic drugs against H. pylori.

Current status of H. pylori research

The improvement of sequencing technology and the detection capability of various testing devices have accelerated the research on H. pylori. From the discovery of H. pylori to the present, the basic situation of H. pylori has been well studied, including the structure and morphology of H. pylori, culture conditions, the distribution of different populations, the evolution of different populations and the types of diseases caused by H. pylori. In addition, the more in-depth studies of H. pylori have been well developed, including survival mechanisms, colonization mechanisms, pathogenic mechanisms, drug resistance mechanisms and immune evasion mechanisms. These studies have deepened our understanding of H. pylori. However, there is still a need for more studies of H. pylori to aid in the development of H. pylori vaccines and drugs.

Fig. 1 In-depth study of H. pylori.Fig. 1 In-depth study of H. pylori.

Our services

Ace Therapeutics helps explore the uncharted territory of H. pylori and provides basic and supporting services to help study H. pylori. We focus on basic research that can provide reference solutions for the treatment of H. pylori and this is clearly reflected in our services.

Studies on the membrane proteins of H. pylori

The outer membrane proteins of H. pylori, especially the adhesins, are associated with H. pylori survival, colonization, pathogenicity and antibiotic resistance. Ace Therapeutics provides research services related to the outer membrane proteins of H. pylori to help discover new therapeutic targets. And we focused more on the study of H. pylori adhesins.

Associations between genetic polymorphisms and gastrointestinal diseases

Genetic polymorphisms in H. pylori and humans have effects on the types of disease caused by H. pylori, but some specific effects remain to be explored. We offer services to explore the relationship between genetic polymorphisms and diseases caused by H. pylori to assist in the study of pathogenic mechanisms.

Studies on H. pylori outer membrane vesicles

The outer membrane vesicles of H. pylori can carry outer membrane proteins and virulence factors. And their production facilitates biofilm formation. These have an impact on the pathogenicity of H. pylori and may influence the choice of treatment options for H. pylori. We offer services to help further study H. pylori outer membrane vesicles to help address questions related to the impact of outer membrane vesicles on disease.

Studies on the integrative and conjugative elements of H. pylori

Integrative and conjugative elements are genetically important variable regions of H. pylori and have been found to be associated with pathogenicity of H. pylori. To this end, we offer three types of services to further help investigate the relationship between integrative and conjugative elements and pathogenicity.


The specific service content and strengths of our services are displayed on the service details page. You can click to view.

Collaborate with us

H. pylori are associated with more than 50% of the world's population and is one of the global concerns. Ace Therapeutics specializes in H. pylori and has a deep understanding of H. pylori. We have the ability to help our clients achieve a deeper exploration of H. pylori and further explore the mechanisms involved in the disease caused by H. pylori. We call on you to work with us to help solve the worldwide problem of H. pylori.

※ All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.